4º Simpósio Médico Anual do ECD Paris, França

Xavier Solanich, MD, PHD
Boulevard de l'Hôpita
Paris, França
1 de abril de 2016

Foto de Grupo do Simpósio Médico de Paris 2016

Resumo do Simpósio

A Erdheim-Chester Disease Global Alliance tem o prazer de fornecer o seguinte resumo das apresentações realizadas no 4º Simpósio Médico Internacional Anual de ECD deste ano, ocorrido em 15 de setembro de 2016, no Hôpital Pitié-Salpêtrière em Paris, França. A reunião permitiu que profissionais médicos colaborassem em pesquisas sobre a ECD, compartilhassem descobertas médicas e discutissem o atendimento ao paciente. Agradecemos ao coanfitrião deste ano, Professor Julien Haroche, MD, PhD; a todos os palestrantes que compartilharam seus dados e conhecimentos durante as discussões em painel; a todos os participantes interessados em aprender mais sobre a ECD; e a todos os envolvidos no planejamento e na realização deste evento de sucesso. Um agradecimento especial aos voluntários que criaram este resumo para a comunidade e para os profissionais que não puderam comparecer.

Programas com a agenda do simpósio

Apresentações

As seguintes apresentações foram realizadas na reunião de 2016. Visite o canal do YouTube da ECD Global Alliance para ver todos os vídeos publicados relacionados à ECD.

PresenterPresentation SlidesVideos
Corrado Campochiaro, MDManagement of ECD Symptoms and Side Effects of TreatmentsManagement of ECD Symptoms and Side Effects of Treatments
Giulio Cavalli, MDAdult Onset (Infratentorial) Leukoencephalopathy as Presenting Manifestation of Erdheim-Chester DiseaseAdult Onset (Infratentorial) Leukoencephalopathy as Presenting Manifestation of Erdheim-Chester Disease
Carine Courtillot, MDEndocrine manifestations in Erdheim-Chester diseaseEndocrine manifestations in Erdheim-Chester disease
Benjamin Durham, MDInsights into the Cell-of-Origin of the Histiocytoses Using Patient-Derived Xenograft Murine ModelsInsights into the Cell-of-Origin of the Histiocytoses Using Patient-Derived Xenograft Murine Models
Marina Ferrarini, MDTailoring Treatment for Erdheim-Chester Disease: Focus on ECDTailoring Treatment for Erdheim-Chester Disease: Focus on ECD
Ronald Go, MDEfficacy of Cladribine (2-CdA) in the Treatment of Erdheim-Chester Disease (ECD)Efficacy of Cladribine (2-CdA) in the Treatment of Erdheim-Chester Disease (ECD)
Filip Janku, MD, PhDEncouraging activity of MEK inhibitor trametinib in patients with Erdheim-Chester disease irrespective of BRAF mutation statusClinical Molecular Profiling to Detect Targetable Alterations in Archival Tumor Tissue and Cell-free DNA from Patients with Erdheim-Chester DiseaseEncouraging activity of MEK inhibitor trametinib in patients with Erdheim-Chester disease irrespective of BRAF mutation statusClinical Molecular Profiling to Detect Targetable Alterations in Archival Tumor Tissue and Cell-free DNA from Patients with Erdheim-Chester Disease
Javier Martin, MD, PhDFuture Genetic Studies in Erdheim-Chester disease – GWAS StudyFuture Genetic Studies in Erdheim-Chester disease – GWAS Study
Kenneth McClain, MD, PhDElevated CSF Osteopontin and Circulating Cells with BRAF Mutations in Patients with Langerhans Cell Histiocytosis-Associated Neurodegeneration -A Model for ECD?Elevated CSF Osteopontin and Circulating Cells with BRAF Mutations in Patients with Langerhans Cell Histiocytosis-Associated Neurodegeneration -A Model for ECD?
Augusto Vaglio, MD, PhDMRI evidence of cardiac involvement in Erdheim-Chester diseaseMRI evidence of cardiac involvement in Erdheim-Chester disease